US 8609088
Intranasal delivery of therapeutic enzymes to the central nervous system for the treatment of lysosomal storage diseases
granted A61KA61K38/46A61K38/465
Quick answer
US patent 8609088 (Intranasal delivery of therapeutic enzymes to the central nervous system for the treatment of lysosomal storage diseases) held by Regents of the University of Minnesota expires Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Regents of the University of Minnesota
- Grant date
- Tue Dec 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K38/46, A61K38/465, A61K38/47, A61K9/0043